<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3E18DACB-05AA-4C71-88FB-C909A8311BB5"><gtr:id>3E18DACB-05AA-4C71-88FB-C909A8311BB5</gtr:id><gtr:name>Birkbeck College</gtr:name><gtr:department>Biological Sciences</gtr:department><gtr:address><gtr:line1>Malet Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 7HX</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3E18DACB-05AA-4C71-88FB-C909A8311BB5"><gtr:id>3E18DACB-05AA-4C71-88FB-C909A8311BB5</gtr:id><gtr:name>Birkbeck College</gtr:name><gtr:address><gtr:line1>Malet Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 7HX</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9AE74485-14F7-42B1-9EC4-966CE0ED18F9"><gtr:id>9AE74485-14F7-42B1-9EC4-966CE0ED18F9</gtr:id><gtr:firstName>Ajit</gtr:firstName><gtr:otherNames>Kumar</gtr:otherNames><gtr:surname>Basak</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/680AABB7-DEFE-4FC5-A4D5-7817C357307A"><gtr:id>680AABB7-DEFE-4FC5-A4D5-7817C357307A</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Moss</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8CA29DC8-9139-4C91-92B5-39BAFF71C29A"><gtr:id>8CA29DC8-9139-4C91-92B5-39BAFF71C29A</gtr:id><gtr:firstName>Claire</gtr:firstName><gtr:otherNames>Elizabeth</gtr:otherNames><gtr:surname>Naylor</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700051"><gtr:id>2AB357FF-1B67-4C70-B0C9-9D1DDA48B902</gtr:id><gtr:title>The Gas-Gangrene Causing Alpha-Toxin: Membrane Interaction and Toxicity</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700051</gtr:grantReference><gtr:abstractText>As is frequently documented in the press, people are getting fatter all the time. In fact, by 2010 one in three of us will be clinically obese. Being overweight carries with it a range of health risks, including an increased likelyhood of developing type II diabetes. Diabetes, in turn, has a number of complications, including increased susceptibility to gengrene of the legs and feet. Gangrene is treated by the amputation of the infected leg, while if left untreated it is invariably fatal. This project aims to increase our understanding of what happens in our bodies once we have gangrene, and thus to increase the effectiveness of the treatment. 

Gas-gangrene is caused predominantly by a single toxin released by a bacterium that has infected an injury. This toxin attachs to and attacks human or animal cell walls. The result of this attack is the release of certain signals that cause changes in the limb and the rest of your body. We are going to study the interaction between the toxin and human cell walls by using light-emitting markers attached to the toxin or the cell wall and by examining the molecular structure of the toxin.

We will identify which parts of the toxin make it interact strongly with cell walls. And, conversely, what features of the cell wall allow the toxin to attach to it. We will find out how we can change the behaviour of the toxin by changing the features of the cell wall and/or the toxin. This will allow us to devise strategies for mitagating the effects of the toxin in real cases.</gtr:abstractText><gtr:technicalSummary>Clostridium perfringens phospholipase C (alpha-toxin) is the key determinant of gas gangrene, a major complication of diabetes. We have solved the 3D crystal structure of this toxin in different chemical environments and also the structures of related enzymes, and have consequently developed a model for toxin-membrane interaction. As a result, we hypothesise that specific features of the enzyme and phospholipid membranes promote this interaction, and that understanding the specificity of the toxin-membrane interaction will allow new approaches to the treatment of disease to be devised. It is this hypothesis which we plan to explore with the work described in this application. We will use fluorescence imaging to investigate the factors that influence membrane binding. An assay for membrane binding will be developed, and used to study how changes to both the toxin (via genetic modification and by comparing the toxin to related enzymes) and the membrane structure (by varying phospholipid composition and cell type) affect the membrane-toxin interaction. Where these studies lead to a substrate analogue with promising characteristics for study by X-ray crystallography, we will determine the atomic resolution structure of the enzyme-substrate complex, in order to identify residues essential for catalytic activity. The structures of related enzymes (from C. bifermentans and C. novyii) will be solved using X-ray crystallographic techniques. In combination with the fluorescence results, this atomic resolution information will allow us to identify which residues confer specificty on the toxin-membrane interaction. Understanding this interaction will enable us to understand how the toxin causes tissue necrosis and systemic disease and thus we will be able to alleviate symptoms in a clinical setting.</gtr:technicalSummary><gtr:fund><gtr:end>2011-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>483781</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Radio Interview</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>B7254FA2-32BE-4540-B19F-37522D53E62D</gtr:id><gtr:impact>Interview for Chinese radio programme about english language and the english in general

None</gtr:impact><gtr:outcomeId>jEeGVknhf1Y</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Video</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>CC65FBC5-226D-4A58-BB62-54A3CF731A4E</gtr:id><gtr:impact>3 minute video describing the results in a paper for the Journal of Nutrition to aid in wider dessemination of research results.

None</gtr:impact><gtr:outcomeId>bUotDgo6vei</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Ministry of Defence</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>D5CF1C30-85BA-455E-BE06-6E46F1C8DABE</gtr:id><gtr:impact>30 Ministry of Defence staff attended an open day where results of research partially-funded by the MoD where presented.

Renewed collaboration with MoD staff.</gtr:impact><gtr:outcomeId>FVTCiARMLoh</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>0D8848BA-1B5D-4F55-A185-E2D0DFC461DE</gtr:id><gtr:impact>Interview with Jenny Murray on Radio 4, enabling dissemination of research to wide audience

None</gtr:impact><gtr:outcomeId>L45FLQjyhoR</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>44C5F742-E23A-4E6C-B92D-3282E941821D</gtr:id><gtr:title>Structure of the food-poisoning Clostridium perfringens enterotoxin reveals similarity to the aerolysin-like pore-forming toxins.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f38c64969cbbeb61c0b598d79fc8c33"><gtr:id>1f38c64969cbbeb61c0b598d79fc8c33</gtr:id><gtr:otherNames>Briggs DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>NqxN2TCPU3f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3114DB4F-0017-423F-B102-1EF0298B97C8</gtr:id><gtr:title>Comparison of a nontoxic variant of Clostridium perfringens a-toxin with the toxic wild-type strain.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b4c687eb15e5d35fe0acbde92cd5152"><gtr:id>0b4c687eb15e5d35fe0acbde92cd5152</gtr:id><gtr:otherNames>Vachieri SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>cHH3CJC1cYd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C93210F-9B65-4D9D-B93D-DC458937A2AA</gtr:id><gtr:title>Structural Insights into Clostridium perfringens Delta Toxin Pore Formation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c63a63a63a4db79d33fd5477e7655995"><gtr:id>c63a63a63a4db79d33fd5477e7655995</gtr:id><gtr:otherNames>Huyet J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13741_21_23805259</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F21B046-56A5-4AD1-BB8F-59DC097E36E7</gtr:id><gtr:title>Identification of zyklopen, a new member of the vertebrate multicopper ferroxidase family, and characterization in rodents and human cells.</gtr:title><gtr:parentPublicationTitle>The Journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36e6bd83dfd373c441dfe6211f736a6c"><gtr:id>36e6bd83dfd373c441dfe6211f736a6c</gtr:id><gtr:otherNames>Chen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3166</gtr:issn><gtr:outcomeId>Xj8RQEnc5vd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B61F9831-2E85-417E-A6DA-185341562743</gtr:id><gtr:title>Structure of a C. perfringens enterotoxin mutant in complex with a modified Claudin-2 extracellular loop 2.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f85e48f230e2207d9bbb47e227e9cef1"><gtr:id>f85e48f230e2207d9bbb47e227e9cef1</gtr:id><gtr:otherNames>Yelland TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>5447b100a87580.01492117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CD2ACB2-DEA1-488F-8EE0-DA8472223569</gtr:id><gtr:title>Crystallization and preliminary X-ray diffraction studies of delta-toxin from Clostridium perfringens.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c63a63a63a4db79d33fd5477e7655995"><gtr:id>c63a63a63a4db79d33fd5477e7655995</gtr:id><gtr:otherNames>Huyet J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>hfyPDgjC5B7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA4C2B18-2EEB-45A0-950B-E2AEE2A3B538</gtr:id><gtr:title>Tackling Toxins</gtr:title><gtr:parentPublicationTitle>International Innovation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93cab7cb6c84e38e7ed79ec12f0808f1"><gtr:id>93cab7cb6c84e38e7ed79ec12f0808f1</gtr:id><gtr:otherNames>Moss, David</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>GRZ848nAfMD</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700051</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>